Jazz Pharmaceuticals plc — Director's Dealing 2017

Jun 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2017-06-23

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-23	Ordinary Shares	S	420	$160.0	Disposed	36902	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 173 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2017.